About: Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1996 (uk) im Mai 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1996 (ast) scientific article published on 01 May 1996 (en)
publication date	wds:Q71156547-CE19CBF4-1472-4244-9B07-95D6372C1CB0
publication date	1996-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71156547-7098FD69-80FC-4ACC-A90C-232C9D6376B9
language of work or name	English
author name string	wds:Q71156547-3C5EB641-7D36-4A19-A617-A26078485200 wds:Q71156547-3F90885A-01FB-45F4-AEDB-94EEBE2B56FB wds:Q71156547-42EFB960-4B30-4420-9797-AF3D58F40AC9 wds:Q71156547-4A594FF8-F548-4DAF-9E17-96D564086FD8 wds:Q71156547-69460DEF-86AD-4CC1-9314-EC0A3D33A915 wds:Q71156547-8F6A5DB6-4417-4395-85ED-1C04C7F3A58C wds:Q71156547-91B49605-68F5-482C-87C8-D8EA32E6F3C0 wds:Q71156547-9ABAF876-6D58-49E0-8E39-8190C4577744
author name string	Nicoli N Pistolesi GF Pirovano GP Spinazzi A Caudana R Morana G Portuese A Di Rito R
rdfs:label	Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application (en) Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (nl)
skos:prefLabel	Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application (en) Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (nl)
name	Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application (en) Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (nl)
title	wds:Q71156547-05CDF590-6DB9-4C45-8A64-77CE9D1C92C4
title	Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application (en)
page(s)	wds:Q71156547-8EDB77E7-92A0-4387-824F-F4CF7ED7F3B7
page(s)	513-520
instance of	wds:Q71156547-5EBABAA0-39FE-4094-A4A7-E5339D250820
instance of	scholarly article
main subject	wds:Q71156547-66230A7E-7BD4-4B19-B6D5-6E0BF3D944DC
main subject	wd:Q1832
PubMed ID	wds:Q71156547-810DB766-AFFF-4620-A43A-6533B3CC209B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8668804
PubMed ID	8668804
published in	wds:Q71156547-B2804F78-C93B-4C5E-8A6B-23FDADACCEC6
published in	Radiology
issue	wds:Q71156547-DDF02C75-1CE0-4D81-9638-7E1EA3C81AA2
volume	wds:Q71156547-AE7052A5-0E1E-4494-B650-E4C2D3A8BF4C
issue	2
volume	199
number of pages	wds:Q71156547-8BD0EA43-442F-43C8-AE93-E4FB0E88FED7
number of pages	8 (xsd:decimal)
DOI	wds:Q71156547-FD0E50DD-C3E8-4E7E-B26F-B9DFE8E02CD6
DOI	http://dx.doi.org/10.1148/RADIOLOGY.199.2.8668804
DOI	10.1148/RADIOLOGY.199.2.8668804
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71156547
is cites work of	Safety of MR liver specific contrast media Imaging diagnosis of colorectal liver metastases Hepatobiliary MR imaging with gadolinium-based contrast agents Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA) Contrast agents for hepatic MRI. Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core Imaging of liver metastases: MRI. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre. Hepatic metastases Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine. Liver metastases of colorectal cancer: US, CT or MR? Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy. Use of contrast agents in oncological imaging: magnetic resonance imaging MR imaging of liver tumors Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial Liver-specific MR imaging contrast agents Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction. MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA. 18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine
is cites work of	wds:Q30378880-11507C0F-02CF-4476-BC45-72D59B24A995 wds:Q35997318-94BA6CD4-AD45-4CC2-9DA9-2D6E5C79F7E6 wds:Q77759706-BFED7E0D-B2BE-4A0E-BAAC-233C27C33762 wds:Q30669419-916957FE-FED4-496E-A4A6-8449189FEBAC wds:Q36963721-AEB83E7A-E7FB-4809-AE1D-B0611D10110F wds:Q53170580-B392A73D-18EA-445A-AFB9-7E82D30897B3 wds:Q24631773-30489DF0-0BE2-43D6-B158-455FEC0A6B17 wds:Q51843474-61AA3198-CE58-4ADA-B22C-25DBB94BFB7F wds:Q43759382-9D33DC93-A07F-46D2-8B88-3AF82F7982B9 wds:Q77979415-16E73598-EA53-4B65-929D-4A1689F461A6 wds:Q28344103-31BF8246-8797-4EB2-A177-6615EA91323B wds:Q45205500-D504A0F2-101D-432B-8DBA-B86C82A21538 wds:Q44644415-C5F97822-44AE-4433-A571-A4AD42286E06 wds:Q46013172-90A65760-4163-4A53-89C0-78228E72E35A wds:Q37969750-6702BB16-214F-411A-8A9F-47608A952255 wds:Q37166741-AF24F448-8890-48A5-8C11-8184EA0EFC1E wds:Q37199260-E57DA44C-9364-4945-9ACB-C7B73251201B wds:Q41729067-594A8BA3-76D4-4B31-8AD2-10F9B4C41810 wds:Q43092621-CC0CAB84-DC4B-4F15-AAB9-90BFBF163A9A wds:Q33880479-1A696DAB-A194-4504-BCF3-D17097C3607E wds:Q32081106-465BEEAB-499F-4A05-96CB-4CC98B36115D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software